Prospective Trial of a Validated Algorithm for Warfarin Dosing
NCT02705976 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 211
Last updated 2016-09-27
Summary
The aim of this study is to perform a randomized trial comparing the use of the algorithm, with dosing of warfarin in standard manual dosage clinical practice, in a high quality anticoagulant setting (PSM). This is done for safety concerns and to ensure good performance of the algorithm when used in a clinical setup. The results from the study are expected to increase our knowledge of efficacy by using the algorithm in clinical practice.
Conditions
- Anticoagulation
Interventions
- OTHER
-
Experimental
The algorithm is based on a model, which is designed to handle time series of daily warfarin intakes and INR values measured at designated time points. Based on these inputs the model is able to suggest a warfarin maintenance dose to achieve target INR value. Model parameters are initially set to population values and gradually, as data is entered into the model, these parameters become patient specific.
- OTHER
-
Active Comparator
Participants were (previously) educated in monitoring the INR values and to adjust the warfarin treatment accordingly to achieve a designated target INR range.
Sponsors & Collaborators
-
Aalborg University Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-09-30
- Primary Completion
- 2015-05-31
- Completion
- 2015-05-31
More Related Trials
-
Anticoagulation Length of ThErapy and Risk of New Adverse evenTs In Venous thromboEmbolism Study
NCT03292666 ·Status: COMPLETED
-
Comparison of Warfarin Dosing Using Decision Model Versus Pharmacogenetic Algorithm
NCT00511173 ·Status: COMPLETED ·Phase: PHASE4
-
Oral Anticoagulant Therapy for Venous Thrombosis - SCOR in Thrombosis
NCT00005684 ·Status: COMPLETED
-
Early Identification of Warfarin Maintenance Dosage
NCT01178034 ·Status: COMPLETED ·Phase: PHASE3
-
Quality of Life and Efficacy Evaluation of Patient Self-monitoring Their Oral Anticoagulation Therapy
NCT01033279 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Direct Oral Anticoagulants as a Prophylactic Anticoagulation of Catheter Induced Thrombosis
NCT05705076 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of a Pharmacogenetic-based Warfarin Dosing Algorithm in Patients
NCT02592980 ·Status: UNKNOWN ·Phase: PHASE4
-
PRospective Evaluation Comparing Initiation of Warfarin StrategiEs (PRECISE): Pharmacogenetic-guided Versus Usual Care
NCT00377143 ·Status: WITHDRAWN ·Phase: PHASE4
-
Multi-Center Single Arm Trial to Determine The Effectiveness of Warfarin Therapy Duration For Heparin-Induced Thrombocytopenia (HIT)
NCT03147638 ·Status: UNKNOWN ·Phase: PHASE3
-
The Association of Warfarin Dosage and Plasma Enantiomer Concentration With the Gene Polymorphisms of CYP and VKOR
NCT00247702 ·Status: UNKNOWN ·Phase: NA
-
3 Months' Versus 6 Months' Anticoagulation in Patients With DVT and/or PE
NCT00365950 ·Status: COMPLETED ·Phase: PHASE4
-
Patient-Centered Anticoagulation Self-Monitoring in Minority Patients
NCT02776566 ·Status: COMPLETED ·Phase: NA
-
Safer Warfarin Treatment
NCT01042067 ·Status: SUSPENDED
-
Assessing the Clinical Benefits of a Pharmacogenetics-Guided Dosing Regiment for Calculating Warfarin Maintenance Dose
NCT00700895 ·Status: UNKNOWN ·Phase: PHASE3
-
Prolongation of the Interval Between Monitoring of Warfarin in Stable Patients
NCT00356759 ·Status: COMPLETED ·Phase: PHASE2
-
AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia
NCT05848713 ·Status: RECRUITING ·Phase: PHASE3
-
Self-management of Anticoagulation Treatment
NCT02864537 ·Status: COMPLETED ·Phase: NA
-
Applying Pharmacogenetics to Warfarin Dosing in Chinese Patients
NCT01610141 ·Status: UNKNOWN ·Phase: PHASE4
-
Genotype-Guided Warfarin Therapy Trial
NCT00904293 ·Status: COMPLETED ·Phase: NA
-
Assessment of 2012 Bioequivalence Standards for Warfarin
NCT02574754 ·Status: COMPLETED ·Phase: PHASE1
-
Optimal Duration of Anticoagulation in Deep Venous Thrombosis
NCT01285661 ·Status: COMPLETED ·Phase: PHASE3
-
inDividual, Targeted thrombosIS Prophylaxis Versus the Standard 'One Size Fits All' Approach in Patients Undergoing Total hIp or Total kNee replaCemenT
NCT06581965 ·Status: RECRUITING ·Phase: PHASE4
-
The Study of Warfarin Maintenance Dose in Chinese Patients
NCT01855737 ·Status: UNKNOWN
-
Fearon Algorithm in Warfarin Patient Self-Management
NCT03911661 ·Status: COMPLETED ·Phase: NA
-
Warfarin Patient Self-management Implementation in the US Healthcare System
NCT04766216 ·Status: RECRUITING ·Phase: NA